These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 9566594)
1. Cannabinoid receptors and their endogenous agonist, anandamide. Axelrod J; Felder CC Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid ligand-receptor signaling in the mouse uterus. Das SK; Paria BC; Chakraborty I; Dey SK Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807 [TBL] [Abstract][Full Text] [Related]
3. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888 [TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506 [TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610 [TBL] [Abstract][Full Text] [Related]
7. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362 [TBL] [Abstract][Full Text] [Related]
8. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related]
9. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Di Marzo V Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. Wiley JL; Ryan WJ; Razdan RK; Martin BR Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024 [TBL] [Abstract][Full Text] [Related]
11. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Paria BC; Das SK; Dey SK Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154 [TBL] [Abstract][Full Text] [Related]
12. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Williams CM; Kirkham TC Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436 [TBL] [Abstract][Full Text] [Related]
13. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Mallet PE; Beninger RJ Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110 [TBL] [Abstract][Full Text] [Related]
14. The cannabinoid system and cytokine network. Klein TW; Lane B; Newton CA; Friedman H Proc Soc Exp Biol Med; 2000 Oct; 225(1):1-8. PubMed ID: 10998193 [TBL] [Abstract][Full Text] [Related]
15. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Shivachar AC; Martin BR; Ellis EF Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904 [TBL] [Abstract][Full Text] [Related]
16. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053 [TBL] [Abstract][Full Text] [Related]
17. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561 [TBL] [Abstract][Full Text] [Related]
18. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569 [TBL] [Abstract][Full Text] [Related]
19. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Smith FL; Fujimori K; Lowe J; Welch SP Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941 [TBL] [Abstract][Full Text] [Related]
20. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. Felder CC; Nielsen A; Briley EM; Palkovits M; Priller J; Axelrod J; Nguyen DN; Richardson JM; Riggin RM; Koppel GA; Paul SM; Becker GW FEBS Lett; 1996 Sep; 393(2-3):231-5. PubMed ID: 8814296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]